Clinical Trial Update: Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing standard-dose versus reduced-dose tacrolimus with sirolimus in renal transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED